Round Rock Advisors’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Round Rock Advisors's PBYI Position: Q3 2026 in Review
Round Rock Advisors held its Puma Biotechnology (PBYI) position steady in Q3 2026 at 128,912 shares worth $1.28M. The position accounts for 0.17% of the portfolio, ranked #73.
Round Rock Advisors first reported a position in PBYI in Q3 2025 and has held it in 5 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Round Rock Advisors held 128,912 shares of Puma Biotechnology worth $1.28M as of Q3 2026.
- Round Rock Advisors left its Puma Biotechnology share count unchanged in Q3 2026.
- Puma Biotechnology made up 0.17% of Round Rock Advisors's portfolio in Q3 2026, its #73 holding.
- Round Rock Advisors first reported a position in Puma Biotechnology in Q3 2025 and has held it in 5 quarters since.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Round Rock Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.